Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kunimed Yeast
- Development stage
- Unknown
- Lead developer
- Kunimed PharmaChem
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Kunimed Yeast (also marketed as Kunimed Natural Yeastar) is an oral nutritional supplement derived from natural brewer's yeast (*Saccharomyces cerevisiae*), developed and manufactured by the Nigerian pharmaceutical company Kunimed PharmaChem. Rich in B-complex vitamins, proteins, amino acids, and essential minerals, it is widely used as a daily health booster. The supplement is primarily marketed to support eye health and vision, enhance lactation and breast milk quality in nursing mothers, improve mental and physical performance, support digestion, and boost immune function.
- Brand names
- Kunimed Natural YeastarKunimed YeastKunimed Yeast PowderKunimed Yeast Tablets
- Other names
- Saccharomyces cerevisiaebrewer's yeastyeast
Beyond the preview
Go deeper on Kunimed Yeast.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kunimed Yeast.